Green tea is a type of brewed tea with several health benefits. Drinking green tea daily may lower your total and LDL cholesterol levels, reducing your risk of heart disease.

New REDUCE-IT data presented at EAS 2026 suggests risk-weighted apoB could better identify residual cardiovascular risk in ...

Taking steps to lower levels of harmful LDL cholesterol at a much earlier stage than current medical practice indicates could ...

“As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination with different doses of a statin, will make it easier for physicians to ...

You might be using an unsupported or outdated browser. To get the best possible experience please use the latest version of Chrome, Firefox, Safari, or Microsoft Edge ...

The 2026 ACC/AHA dyslipidemia guidelines mark a major shift toward starting cholesterol treatment earlier and aiming for lower LDL targets. Using the new PREVENT-ASCVD calculator, clinicians can ...

Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart ...

More intensive use of lipid-lowering drugs to reach a lower target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular (CV) events by one third among people with ...

There are two main types of cholesterol in the body — HDL or “good” cholesterol, and LDL or “bad” cholesterol. Having higher levels of LDL cholesterol can potentially lead to atherosclerosis and ...

For patients with atherosclerotic cardiovascular disease (ASCVD), targeting a low-density lipoprotein (LDL) cholesterol level of <55 mg/dL results in a lower risk for cardiovascular events, according ...

Despite guideline recommendations, evidence from randomized trials evaluating the appropriate low-density lipoprotein (LDL) cholesterol target for secondary prevention in patients with atherosclerotic ...

A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the ...